Can a phone app cure your insomnia? new trial tests sound therapy that syncs with your breath

NCT ID NCT07295431

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a smartphone app called BELL-001 that plays personalized sounds in sync with your breathing to help you relax and fall asleep. 114 adults with insomnia will use the app or a sham version nightly for 4 weeks. Researchers will measure changes in sleep quality and daytime function to see if the app works as a safe, drug-free treatment.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
smartphone-based digital therapeutic delivering personalized auditory stimulation synchronized with breathing
What this could lead to
If successful, this could provide a safe, non-drug option to help people with insomnia fall asleep more easily and improve daytime function.
What could go wrong
This is an early-stage trial with only 114 participants, and the sham control may show similar effects. The app may not work for everyone, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHA Bundang Hospital

    Seoul, South Korea

  • Catholic Kwandong University International St. Mary's Hospital

    Seoul, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, South Korea

  • Kyung Hee University Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.